US Patent

US10076614 — Nasal delivery devices

Formulation · Assigned to Optinose AS · Expires 2034-10-20 · 8y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a nasal delivery device with a flexible coupling that allows for asymmetric movement of its parts.

USPTO Abstract

A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing ( 15 ); a nosepiece ( 17 ) for fitting to a nasal cavity of the subject; a mouthpiece ( 19 ) through which the subject in use exhales; and a flexible coupling ( 20 ) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece.

Drugs covered by this patent

Patent Metadata

Patent number
US10076614
Jurisdiction
US
Classification
Formulation
Expires
2034-10-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.